Thermo Fisher Scientific
In Leon Cooperman's portfolio · Omega Advisors
Ticker TMO
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Omega Advisors 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q4 2019 | Sell | 0 | |
| Q3 2019 | Reduce 80% | 22,600 | 0.4% |
| Q2 2019 | No change | 112,200 | 2.0% |
| Q1 2019 | No change | 112,200 | 1.9% |
| Q4 2018 | Reduce 55% | 112,200 | 2.5% |
| Q3 2018 | Reduce 4% | 248,200 | 2.6% |
| Q2 2018 | Add 25% | 258,400 | 1.9% |
| Q1 2018 | Buy | 207,400 | 1.6% |
| Q4 2014 | Sell | 0 | |
| Q3 2014 | Reduce 4% | 864,000 | 1.5% |
| Q2 2014 | Add 6% | 898,800 | 1.4% |
| Q1 2014 | Add 3% | 847,800 | 1.4% |
| Q4 2013 | Add 34% | 825,000 | 1.3% |
| Q3 2013 | Add 26% | 615,370 | 0.9% |
| Q2 2013 | First 13F | 488,670 | 0.6% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.